I Holland to share the science behind tool maintenance
Proper maintenance - rather than replacement - of compression tooling will improve profitability.
I Holland will once again share its knowledge with tablet compression manufacturers by hosting a free webinar which investigates the science behind professional punch and die maintenance, and how it will improve profitability.
The webinar, to be held on 15 August, will examine the challenges of tool maintenance and the science behind it. It will follow I Holland's PharmaCare 7 Step Process, a logical, professional approach to tooling maintenance and storage which has already been adopted by many companies around the world as a Standard Operating Procedure.
“Tooling maintenance is internationally recognised by manufacturers and customers around the world to be a necessity,” explains Marianna D’Onghia, I Holland marketing co-ordinator. “The reason behind it is simple. Compression tooling should not be viewed simply as consumable items that are easily replaced. Instead, we argue that if you take care and follow proper maintenance and management procedures, your tooling will last longer. The result is less tablet press downtime and a significant return on investment from not having to replace your tools constantly.”
The webinar will detail each of the 7 steps and explain the options available in the marketplace, the recommended method and the science behind the method.
“This free web presentation will aim to teach you the how and the why,” continued Marianna. “The webinar concentrates on four main areas. Understanding the reasons why we recommend that you carry out each of the steps; a thorough review of equipment options available in the marketplace to carry out each step; the preferred method and its associated benefits; and finally the science behind both the step and the preferred method. We will answer the question why each of the steps is important, really exploring the science behind maintenance techniques and getting into the finer details and scientific facts.
“Implementing a planned, professional maintenance process is key to getting the best from your tooling and ultimately helping to improve profitability in tablet production. We hope those that sign up to the free webinar will leave the educational session feeling more knowledgeable about the importance of proper tool maintenance.”
This webinar will explain why correct tooling maintenance is critical in order to obtain the maximum life from punches and dies. Re-emphasizing that the application of a structured maintenance process results in the direct impact on the reduction of many common tablet and tooling problems. By adopting these recommended ‘best practices’ tablet manufacturers will ensure the maximum life from tablet tooling is achieved, an increase in production and direct cost savings.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance